Portugal as a health innovation platform
Portugal is positioned as a hub for developing and implementing new solutions in the healthcare sector.
Biotech news in Portugal
Latest news and stories about biotech in Portugal for expats and residents.
Latest news and stories about biotech in Portugal for expats and residents.
Portugal is positioned as a hub for developing and implementing new solutions in the healthcare sector.
How can drugs be delivered to tumours without affecting normal cells? Scientists at Técnico are trying to answer this question by studying what was previously thought to be just waste released by cells.
HPRD, which manages the Labfit and Pharmapoli brands, researches and manufactures products for the pharmaceutical and cosmetic industries. With a focus on women's intimate health, it aims to become an international reference, says Ana Palmeira de Oliveira.
HPRD was founded in 2012, originating from the University of Beira Interior, with the development and subsequent production of a vaginal application product to solve a dermal problem in the vulva. Ana Palmeira de Oliveira, who chairs the company, tells the “Liga dos Inovadores” how this project emerged, which later evolved into other industries, such as cosmetics.
The company marks its 25th anniversary in the Portuguese market, highlighting its ongoing focus on health prevention and scientific research.
Biotechnology drives cutting-edge medical innovation but is constrained by Europe’s fragmented regulatory landscape. The Biotech Act offers a critical opportunity to remove structural barriers, harmonize frameworks and accelerate patient access.
Biorce closed a $52.5 million funding round (about €44 million) to speed up its international expansion and 'lead the transformation of clinical trials through AI'. By the end of the year the startup aims to grow its team to 250 people and is preparing to open an office in Barcelona.
The startup of researcher Ângela Relógio, TimeTeller, won the Hamburg Founders' Prize 2025, adding to other accolades earned by the company responsible for measuring individual circadian rhythms at the molecular level.
